Literature DB >> 21799039

"Brush Sign" on susceptibility-weighted MR imaging indicates the severity of moyamoya disease.

N Horie1, M Morikawa, A Nozaki, K Hayashi, K Suyama, I Nagata.   

Abstract

BACKGROUND AND
PURPOSE: SWI is a high spatial resolution MR imaging technique showing magnetic inhomogeneity that could demonstrate increased oxygen extraction in focal cerebral ischemia. The aim of this study was to investigate the characteristics in the signal intensity of DMVs by using SWI and to determine whether this method could indicate the severity of the hemodynamics in MMD by evaluating the correlation between SWI stage and hemodynamics on SPECT.
MATERIALS AND METHODS: Consecutive MMD patients were prospectively analyzed before treatment. Routine MR imaging including SWI was performed, and the number of the conspicuous DMVs draining into the subependymal veins was classified: stage 1, mild (< 5); stage 2, moderate (5-10); and stage 3, severe (> 10). The SWI stage was evaluated in correlation with clinical presentations, and CBF and CVR were quantified by using a SPECT iodine 123 N-isopropyl-p-iodoamphetamine split-dose method.
RESULTS: Patients were 12 males and 21 females (range, 8-66 years), consisting of 4 asymptomatic patients, 13 patients with TIA, 9 patients with infarct, and 7 patients with hemorrhage. There was a significant difference in CVR among clinical presentations, though there was no difference in age, Suzuki stage, or CBF. Conversely, SWI stage was significantly higher in patients with TIA and infarct than asymptomatic patients (P < .01). Higher SWI stage significantly had lower CBF and CVR in the middle cerebral artery area (P < .05).
CONCLUSIONS: SWI stage strongly correlates with ischemic presentations in MMD and also correlates with hemodynamics on SPECT, especially CVR. Increased conspicuity of DMVs, known as "brush sign", could predict the severity of MMD.

Entities:  

Mesh:

Year:  2011        PMID: 21799039      PMCID: PMC7965393          DOI: 10.3174/ajnr.A2568

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  34 in total

1.  High-resolution blood oxygen-level dependent MR venography (HRBV): a new technique.

Authors:  J R Reichenbach; L Jonetz-Mentzel; C Fitzek; E M Haacke; D K Kido; B C Lee; W A Kaiser
Journal:  Neuroradiology       Date:  2001-05       Impact factor: 2.804

Review 2.  Clinical applications of neuroimaging with susceptibility-weighted imaging.

Authors:  Vivek Sehgal; Zachary Delproposto; E Mark Haacke; Karen A Tong; Nathaniel Wycliffe; Daniel K Kido; Yingbiao Xu; Jaladhar Neelavalli; Djamel Haddar; Jürgen R Reichenbach
Journal:  J Magn Reson Imaging       Date:  2005-10       Impact factor: 4.813

3.  Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses.

Authors:  Vivek Sehgal; Zachary Delproposto; Djamel Haddar; E Mark Haacke; Andrew E Sloan; Lucia J Zamorano; Geoffery Barger; Jiani Hu; Yingbiao Xu; Karthik Praveen Prabhakaran; Ilaya R Elangovan; Jaladhar Neelavalli; Jürgen R Reichenbach
Journal:  J Magn Reson Imaging       Date:  2006-07       Impact factor: 4.813

Review 4.  Quantitative hemodynamic studies in moyamoya disease: a review.

Authors:  Marco Lee; Greg Zaharchuk; Raphael Guzman; Achal Achrol; Teresa Bell-Stephens; Gary K Steinberg
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

5.  Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study.

Authors:  Ken-Ichiro Kikuta; Yasushi Takagi; Kazuhiko Nozaki; Takashi Hanakawa; Tsutomu Okada; Nobuhro Mikuni; Yukio Miki; Yasutaka Fushmi; Akira Yamamoto; Keisuke Yamada; Hidenao Fukuyama; Nobuo Hashimoto
Journal:  J Neurosurg       Date:  2005-03       Impact factor: 5.115

6.  Cortical T2 signal shortening in amyotrophic lateral sclerosis is not due to iron deposits.

Authors:  M J Hecht; C Fellner; A Schmid; B Neundörfer; F A Fellner
Journal:  Neuroradiology       Date:  2005-09-21       Impact factor: 2.804

7.  Moyamoya disease--a review.

Authors:  J Suzuki; N Kodama
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

8.  Long-term natural history of hemorrhagic moyamoya disease in 42 patients.

Authors:  E Kobayashi; N Saeki; H Oishi; S Hirai; A Yamaura
Journal:  J Neurosurg       Date:  2000-12       Impact factor: 5.115

9.  Cerebral hemodynamics and metabolism in adult moyamoya disease: comparison of angiographic collateral circulation.

Authors:  Rishu Piao; Naohiko Oku; Kazuo Kitagawa; Masao Imaizumi; Kohji Matsushita; Takuya Yoshikawa; Masashi Takasawa; Yasuhiro Osaki; Yasuyuki Kimura; Katsufumi Kajimoto; Masatsugu Hori; Jun Hatazawa
Journal:  Ann Nucl Med       Date:  2004-04       Impact factor: 2.668

10.  Detection of misery perfusion with split-dose 123I-iodoamphetamine single-photon emission computed tomography in patients with carotid occlusive diseases.

Authors:  Masao Imaizumi; Kazuo Kitagawa; Kazuo Hashikawa; Naohiko Oku; Tadamasa Teratani; Masashi Takasawa; Takuya Yoshikawa; Piao Rishu; Toshiho Ohtsuki; Masatsugu Hori; Masayasu Matsumoto; Tsunehiko Nishimura
Journal:  Stroke       Date:  2002-09       Impact factor: 7.914

View more
  13 in total

1.  Prominence of Medullary Veins on Susceptibility-Weighted Images Provides Prognostic Information in Patients with Subacute Stroke.

Authors:  X Yu; L Yuan; A Jackson; J Sun; P Huang; X Xu; Y Mao; M Lou; Q Jiang; M Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-29       Impact factor: 3.825

2.  Brush sign in Sturge-Weber syndrome.

Authors:  Arsany Hakim; Diana Aguiar de Sousa
Journal:  Pediatr Radiol       Date:  2018-02-19

Review 3.  Neuroimaging at 7 Tesla: a pictorial narrative review.

Authors:  Tomohisa Okada; Koji Fujimoto; Yasutaka Fushimi; Thai Akasaka; Dinh H D Thuy; Atsushi Shima; Nobukatsu Sawamoto; Naoya Oishi; Zhilin Zhang; Takeshi Funaki; Yuji Nakamoto; Toshiya Murai; Susumu Miyamoto; Ryosuke Takahashi; Tadashi Isa
Journal:  Quant Imaging Med Surg       Date:  2022-06

4.  Moyamoya disease: a spectrum of clinical and radiological findings in a series of eight paediatric patients.

Authors:  Sudeshna Malakar; Amlan Kusum Datta; Uddalak Chakraborty; Jasodhara Chaudhury; Swati Kumar; Atanu Chandra; Biman Kanti Ray
Journal:  Acta Neurol Belg       Date:  2021-02-04       Impact factor: 2.396

5.  Early manifestation of Moyamoya syndrome in a 2-year-old child with Down syndrome.

Authors:  Abasin Tajmalzai; Asadullah Shirzai; Din Mohammad Najah
Journal:  Radiol Case Rep       Date:  2021-05-01

6.  Clinicoepidemiological features of asymptomatic moyamoya disease in adult patients.

Authors:  Jeyul Yang; Joo Chul Hong; Chang Wan Oh; O-Ki Kwon; Gyojun Hwang; Jeong Eun Kim; Hyun-Seung Kang; Won-Sang Cho; Tackeun Kim; Jong Un Moon; Seong Yeol Ahn; Jun Hak Kim; Jae Seung Bang
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2014-09-30

7.  The Value of Susceptibility-Weighted Imaging (SWI) in Evaluating the Ischemic Penumbra of Patients with Acute Cerebral Ischemic Stroke.

Authors:  Yong-Ren Wang; Zhao-Sheng Li; Wei Huang; Hui-Qiang Yang; Bo Gao; Yu-Ting Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-03       Impact factor: 2.570

8.  Relationship between deep medullary veins in susceptibility-weighted imaging and ipsilateral cerebrovascular reactivity of middle cerebral artery in patients with ischemic stroke.

Authors:  Xianjun Han; Linhui Ouyang; Chunning Zhang; Hailing Ma; Jingcui Qin
Journal:  Exp Ther Med       Date:  2016-03-28       Impact factor: 2.447

9.  A Comparison Study of Single-Echo Susceptibility Weighted Imaging and Combined Multi-Echo Susceptibility Weighted Imaging in Visualizing Asymmetric Medullary Veins in Stroke Patients.

Authors:  Chao Wang; Tiantian Qiu; Ruirui Song; Yerfan Jiaerken; Linglin Yang; Shaoze Wang; Minming Zhang; Xinfeng Yu
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

Review 10.  Susceptibility-weighted Imaging in Thrombolytic Therapy of Acute Ischemic Stroke.

Authors:  Lin Li; Ming-Su Liu; Guang-Qin Li; Yang Zheng; Tong-Li Guo; Xin Kang; Mao-Ting Yuan
Journal:  Chin Med J (Engl)       Date:  2017-10-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.